In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Encore Vision, Inc.

http://encorevisioninc.com/

Latest From Encore Vision, Inc.

Novartis Hopes Lubris In-Licensing Deal Will Lead To Dry Eye Solution

ON the lookout for potential ophthalmology options despite recent setbacks in the area, Novartis has now spotted ECF843, an investigative recombinant human lubricin – or natural lubricant – for dry eye.

Commercial Companies

Novartis’s Evolving R&D: An Interview With CMO Narasimhan At J.P. Morgan

Novartis is under pressure to deliver new drugs in areas like oncology, cardiovascular disease and dermatology, where it is making significant investments. Chief Medical Officer Vasant Narasimhan talked about the company’s strategy in these areas and others, the company’s recent R&D reorganization and business development in an interview during the J.P. Morgan Healthcare Conference.

Commercial Companies

Deals Shaping the Medical Industry, January 2017

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in December 2016.

Deals BioPharmaceutical

More from the Device Innovators' Workbench

Interviews with medical device inventors/entrepreneurs Rodney Perkins, MD, and Mir Imran, discussing their successes, such as Collagen and PercuSurge, and the ones that didn't make it.

Medical Device Business Strategies
See All

Company Information

  • Other Names / Subsidiaries
    • Encore Health, LLC
UsernamePublicRestriction

Register